Nanobiotix (NASDAQ:NBTX) Stock Jumps 5.9% – Here’s What Happened

Nanobiotix S.A. – Sponsored ADR (NASDAQ:NBTX) shares were up 5.9% during mid-day trading on Monday. The company traded as high as $31.18 and last traded at $31.1060. Approximately 5,710 shares were traded during mid-day trading, a decline of 94% from the average session volume of 94,543 shares. The stock had previously closed at $29.36.

Wall Street Analysts Forecast Growth

NBTX has been the topic of a number of research analyst reports. Weiss Ratings reissued a “sell (d-)” rating on shares of Nanobiotix in a report on Thursday, October 15th. Guggenheim initiated coverage on shares of Nanobiotix in a research report on Tuesday, September 15th. They set a “buy” rating and a $64.00 price target for the company. Four analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $46.67.

Nanobiotix Price Performance

The firm’s fifty day simple moving average is $33.15 and its 200-day simple moving average is $33.53.

About Nanobiotix

Nanobiotix is a biotechnology company developing nanoparticle-based therapies designed to improve the effectiveness of radiotherapy in cancer treatment. The company’s technology uses hafnium oxide nanoparticles that are injected directly into a tumor and activated by ionizing radiation, with the goal of increasing energy deposition within cancer cells while limiting exposure to surrounding tissue.

Nanobiotix’s lead product candidate, NBTXR3, is being evaluated in clinical studies across several cancer types, including locally advanced head and neck cancer and other solid tumors.